Why Are Clinical Trials Not Typically a Care Option? episode artwork

EPISODE · Feb 5, 2019 · 44 MIN

Why Are Clinical Trials Not Typically a Care Option?

from PharmaTalkRadio · host Conference Forum

Murray Abramson, MD, VP Clinical Operations, Biogen and Jeff James, CEO, Wilmington Health, discuss the blockers and enablers to making clinical research a care option. Discuss includes: What are the blockers or conflicts (laws, culture, behaviors, etc) that prevent clinical research from becoming a care option?What is the difference between a movement and an initiative - how should be think about clinical research as a care option? Benefits?What are the enablers or requirements to incorporate clinical research into care options for the patient?How to pave a path for possibilityUpdate on data to support how trials can be a care option This discussion was held at the Clinical Research as a Care Option (CRAACO) meeting held April 11, 2018 in Cambridge, MA. The 2019 CRAACO meeting will take place April 29-30 in Raleigh-Durham, NC. Find out more here.

Murray Abramson, MD, VP Clinical Operations, Biogen and Jeff James, CEO, Wilmington Health, discuss the blockers and enablers to making clinical research a care option. Discuss includes: What are the blockers or conflicts (laws, culture, behaviors, etc) that prevent clinical research from becoming a care option?What is the difference between a movement and an initiative - how should be think about clinical research as a care option? Benefits?What are the enablers or requirements to incorporate clinical research into care options for the patient?How to pave a path for possibilityUpdate on data to support how trials can be a care option This discussion was held at the Clinical Research as a Care Option (CRAACO) meeting held April 11, 2018 in Cambridge, MA. The 2019 CRAACO meeting will take place April 29-30 in Raleigh-Durham, NC. Find out more here.

NOW PLAYING

Why Are Clinical Trials Not Typically a Care Option?

0:00 44:59

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of PharmaTalkRadio?

This episode is 44 minutes long.

When was this PharmaTalkRadio episode published?

This episode was published on February 5, 2019.

What is this episode about?

Murray Abramson, MD, VP Clinical Operations, Biogen and Jeff James, CEO, Wilmington Health, discuss the blockers and enablers to making clinical research a care option. Discuss includes: What are the blockers or conflicts (laws, culture, behaviors,...

Can I download this PharmaTalkRadio episode?

Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.
URL copied to clipboard!